Delivery Order SPE2DB24D1006-SPE2DB25FCEQS

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Progesterone 100 mg capsules, valued at $13,434.45. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,560.45, is for the delivery of Progesterone 100 mg Capsules in quantities of 100s. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,127.74, is for the delivery of Progesterone 100 mg capsules in packs of 30 to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $18,557.07, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567752016 - Progesterone 200 mg Capsule 100s. This appears to be a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 1, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,456.09, is a delivery order for the supply of 4567726860 - Progesterone 100 mg Capsule 100s. The contract has an ultimate completion date of March 31, 2025 and uses a firm fixed price pricing type. This contract award is associated with AmerisourceBergen's larger Indefinite Delivery Contract...
This federal contract award, valued at $11,961.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,925,357 units of Progesterone 200 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award, valued at $1,321.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568078090 - Progesterone 200 mg Capsules, 100s, and has an ultimate completion date of April 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award, valued at $20,044.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4,567,916,240 units of Progesterone 200 mg capsules, with an ultimate completion date of April 16, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial...
This federal contract award, valued at $22,962.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567908583 - Progesterone 200 mg Capsule 100s, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 15, 2025. The contract is not set aside for any specific business category. Amerisourcebergen...
This federal contract award, valued at $3,359.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Progesterone 200 mg capsules (100s) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB24D1006
    Indefinite Delivery Contract
  • SPE2DB24D1006-SPE2DB25FCEQS
    Delivery Order

This federal contract award, valued at $7,079.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568201410 - Progesterone 100 mg Capsules (100s) and does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard, among other government agencies.

Generated 8/8/25, 9:51 AM